David Ku

David Ku, MD has extensive work experience in corporate development, portfolio strategy, and management. David currently holds the position of Vice President at Jasper Therapeutics, where they are responsible for corporate development and portfolio strategy. Prior to this, they served as a Senior Director of Business Development and Finance at the same company.

Before joining Jasper Therapeutics, David worked at Gilead Sciences as a Director of Strategic Planning. David'srole involved developing strategic plans for the company.

Prior to their time at Gilead, David worked at McKinsey & Company, where they held various positions. David started as an Associate and later became an Engagement Manager. During their time at McKinsey, they gained experience in strategic planning and project management.

David also has research experience from their time at the Massachusetts Institute of Technology (MIT), specifically in the High-Throughput Neurotechnology Group.

Overall, David Ku, MD brings a diverse background in corporate development, business strategy, and research to their current role at Jasper Therapeutics.

David Ku, MD completed their Bachelor of Science degree in Electrical Engineering & Computer Science from the Massachusetts Institute of Technology in 2012. In 2016, they earned their Doctor of Medicine degree from the Icahn School of Medicine at Mount Sinai.